Barclays’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $316K | Sell |
89,970
-302,934
| -77% | -$1.24M | ﹤0.01% | 3450 |
|
|
2025
Q4 | $1.32M | Buy |
392,904
+95,586
| +32% | +$248K | ﹤0.01% | 3241 |
|
|
2025
Q3 | $389K | Sell |
297,318
-68,132
| -19% | -$70.5K | ﹤0.01% | 3957 |
|
|
2025
Q2 | $262K | Buy |
365,450
+36,061
| +11% | +$28.3K | ﹤0.01% | 4115 |
|
|
2025
Q1 | $484K | Sell |
329,389
-39,887
| -11% | -$95K | ﹤0.01% | 3553 |
|
|
2024
Q4 | $1.64M | Sell |
369,276
-47,044
| -11% | -$191K | ﹤0.01% | 3051 |
|
|
2024
Q3 | $1.72M | Buy |
416,320
+219,304
| +111% | +$1.18M | ﹤0.01% | 2978 |
|
|
2024
Q2 | $1.28M | Sell |
197,016
-93,229
| -32% | -$659K | ﹤0.01% | 2447 |
|
|
2024
Q1 | $2.53M | Sell |
290,245
-262,323
| -47% | -$3.18M | ﹤0.01% | 2381 |
|
|
2023
Q4 | $6.32M | Sell |
552,568
-26,104
| -5% | -$258K | ﹤0.01% | 1897 |
|
|
2023
Q3 | $5.57M | Buy |
578,672
+123,874
| +27% | +$1.21M | ﹤0.01% | 1263 |
|
|
2023
Q2 | $4.84M | Buy |
454,798
+121,785
| +37% | +$1.31M | ﹤0.01% | 1367 |
|
|
2023
Q1 | $3.5M | Sell |
333,013
-143,186
| -30% | -$1.6M | ﹤0.01% | 1785 |
|
|
2022
Q4 | $5.9M | Sell |
476,199
-98,296
| -17% | -$1.12M | ﹤0.01% | 1506 |
|
|
2022
Q3 | $5.95M | Buy |
574,495
+453,988
| +377% | +$5.15M | 0.01% | 1064 |
|
|
2022
Q2 | $1.39M | Sell |
120,507
-335,591
| -74% | -$3.95M | ﹤0.01% | 2108 |
|
|
2022
Q1 | $5.74M | Buy |
456,098
+233,894
| +105% | +$2.68M | ﹤0.01% | 1173 |
|
|
2021
Q4 | $2.59M | Buy |
222,204
+6,488
| +3% | +$79.6K | ﹤0.01% | 2210 |
|
|
2021
Q3 | $2.82M | Sell |
215,716
-9,639
| -4% | -$125K | ﹤0.01% | 2067 |
|
|
2021
Q2 | $2.9M | Sell |
225,355
-217,046
| -49% | -$2.48M | ﹤0.01% | 1936 |
|
|
2021
Q1 | $4.95M | Buy |
442,401
+65,173
| +17% | +$688K | ﹤0.01% | 1525 |
|
|
2020
Q4 | $4.3M | Sell |
377,228
-114,182
| -23% | -$1.25M | ﹤0.01% | 1616 |
|
|
2020
Q3 | $4.42M | Buy |
491,410
+214,377
| +77% | +$2.13M | ﹤0.01% | 1476 |
|
|
2020
Q2 | $2.86M | Buy |
277,033
+46,565
| +20% | +$477K | ﹤0.01% | 1798 |
|
|
2020
Q1 | $2.33M | Buy |
230,468
+62,652
| +37% | +$736K | ﹤0.01% | 2157 |
|
|
2019
Q4 | $2.23M | Buy |
167,816
+70,667
| +73% | +$779K | ﹤0.01% | 2885 |
|
|
2019
Q3 | $833K | Sell |
97,149
-51,879
| -35% | -$504K | ﹤0.01% | 3827 |
|
|
2019
Q2 | $1.63M | Sell |
149,028
-140,875
| -49% | -$1.58M | ﹤0.01% | 3157 |
|
|
2019
Q1 | $3.29M | Buy |
289,903
+72,883
| +34% | +$814K | ﹤0.01% | 2047 |
|
|
2018
Q4 | $1.88M | Buy |
217,020
+137,096
| +172% | +$1.57M | ﹤0.01% | 2469 |
|
|
2018
Q3 | $1.24M | Buy |
79,924
+67,806
| +560% | +$1.07M | ﹤0.01% | 3429 |
|
|
2018
Q2 | $194K | Sell |
12,118
-27,499
| -69% | -$407K | ﹤0.01% | 4748 |
|
|
2018
Q1 | $511K | Sell |
39,617
-144,466
| -78% | -$1.8M | ﹤0.01% | 3953 |
|
|
2017
Q4 | $2.31M | Buy |
184,083
+177,994
| +2,923% | +$2.32M | ﹤0.01% | 2298 |
|
|
2017
Q3 | $80K | Buy |
6,089
+4,602
| +309% | +$63.3K | ﹤0.01% | 5080 |
|
|
2017
Q2 | $24K | Sell |
1,487
-3,468
| -70% | -$50.4K | ﹤0.01% | 5704 |
|
|
2017
Q1 | $71K | Sell |
4,955
-11,660
| -70% | -$159K | ﹤0.01% | 5125 |
|
|
2016
Q4 | $213K | Sell |
16,615
-522
| -3% | -$6.59K | ﹤0.01% | 4171 |
|
|
2016
Q3 | $227K | Sell |
17,137
-199,001
| -92% | -$2.33M | ﹤0.01% | 3865 |
|
|
2016
Q2 | $2.37M | Buy |
216,138
+146,103
| +209% | +$1.43M | ﹤0.01% | 1875 |
|
|
2016
Q1 | $587K | Buy |
70,035
+25,338
| +57% | +$209K | ﹤0.01% | 3016 |
|
|
2015
Q4 | $412K | Sell |
44,697
-62,900
| -58% | -$608K | ﹤0.01% | 3355 |
|
|
2015
Q3 | $902K | Buy |
107,597
+26,631
| +33% | +$248K | ﹤0.01% | 2825 |
|
|
2015
Q2 | $813K | Buy |
80,966
+68,232
| +536% | +$793K | ﹤0.01% | 3071 |
|
|
2015
Q1 | $171K | Sell |
12,734
-4,228
| -25% | -$55.5K | ﹤0.01% | 4462 |
|
|
2014
Q4 | $214K | Sell |
16,962
-4,682
| -22% | -$53.6K | ﹤0.01% | 4577 |
|
|
2014
Q3 | $217K | Sell |
21,644
-141,028
| -87% | -$1.61M | ﹤0.01% | 4686 |
|
|
2014
Q2 | $2.04M | Buy |
162,672
+137,432
| +545% | +$1.49M | ﹤0.01% | 2572 |
|
|
2014
Q1 | $253K | Buy |
25,240
+11,039
| +78% | +$124K | ﹤0.01% | 4574 |
|
|
2013
Q4 | $132K | Sell |
14,201
-34,416
| -71% | -$309K | ﹤0.01% | 5399 |
|
|
2013
Q3 | $447K | Sell |
48,617
-109,855
| -69% | -$1.08M | ﹤0.01% | 4239 |
|
|
2013
Q2 | $1.32M | Buy |
+158,472
| New | +$1.92M | ﹤0.01% | 3029 |
|
Other funds holding IRWD
AC
SCM
VPM
VCM
Barclays's IRWD Position: Q1 2026 in Review
Barclays reduced its Ironwood Pharmaceuticals (IRWD) stake by 77% in Q1 2026, selling an estimated $1.24M and leaving 89,970 shares worth $316K. The position accounts for ﹤0.01% of the portfolio, ranked #3450.
Barclays first reported a position in IRWD in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.32M in Q4 2023. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.
- Barclays held 89,970 shares of Ironwood Pharmaceuticals worth $316K as of Q1 2026.
- Barclays sold 302,934 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $1.24M.
- Ironwood Pharmaceuticals made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3450 holding.
- Barclays first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Barclays's Ironwood Pharmaceuticals position peaked at $6.32M in Q4 2023.
- 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.